Brief: Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update

Agile Therapeutics

11/05/2023 21:48

Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES  CORPORATE UPDATE
    * AGILE THERAPEUTICS INC Q1 NON-GAAP LOSS PER SHARE $7.76
    * AGILE THERAPEUTICS INC Q1 GAAP LOSS PER SHARE $5.91
    * AGILE THERAPEUTICS INC Q1 REVENUE ROSE 117 PERCENT TO $3.8
MILLION
    * AGILE THERAPEUTICS INC - REAFFIRMS EXPECTED FULL YEAR 2023
NET
REVENUE IN RANGE OF $25 MILLION - $30 MILLION
    * AGILE THERAPEUTICS INC - AS OF MARCH 31, 2023, CO HAD $4.4
MILLION OF CASH, COMPARED TO $5.2 MILLION OF CASH AND CASH
EQUIVALENTS AS OF END OF Q4 2022

Source text for Eikon:  ID:nGNX4wSbk5 
Further company coverage:  AGRX.O